| 2024-03-27 | Nkarta, Inc. NKTX | director | 2M 3.6511% | $10.00 | $20M | -38.48% | ||
| 2022-12-20 | Design Therapeutics, Inc. DSGN | director | 40,000 0.0725% | $8.14 | $325,432 | -27.73% | ||
| 2022-12-19 | Design Therapeutics, Inc. DSGN | director | 360,000 0.6698% | $8.63 | $3.11M | -29.65% | ||
| 2022-12-16 | Design Therapeutics, Inc. DSGN | director | 500,000 0.8485% | $8.28 | $4.14M | -32.42% | ||
| 2022-04-28 | Nkarta, Inc. NKTX | 666,667 1.2658% | $15.00 | $10M | -32.41% | |||
| 2021-03-30 | Design Therapeutics, Inc. DSGN | 250,000 0.9607% | $20.00 | $5M | -40.99% | |||
| 2016-10-24 | CRISPR Therapeutics AG CRSP | director | 133,000 1.0843% | $14.00 | $1.86M | +31.44% |